We proceeded to analyze the four IDH mutations shown in Fig. 5 in BM aspirates from a cohort of 22 patients with myeloid malignancies, including AML, MDS and myeloproliferative neoplasia. This evidence concerns the gene IDH1 and myeloid neoplasm.